Details for New Drug Application (NDA): 070998
✉ Email this page to a colleague
The generic ingredient in K+8 is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 070998
| Tradename: | K+8 |
| Applicant: | Future Pak |
| Ingredient: | potassium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 8MEQ | ||||
| Approval Date: | Jan 25, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
